Longitudinal associations between physical activity and five risk factors of metabolic syndrome in middle-aged adults in Germany.
Abdominal obesity
Diabetes
Exercise
Hyperlipidemia
Hypertension
Longitudinal study
Metabolic syndrome
Physical activity
Journal
Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958
Informations de publication
Date de publication:
26 Apr 2023
26 Apr 2023
Historique:
received:
28
03
2023
accepted:
14
04
2023
medline:
26
4
2023
pubmed:
26
4
2023
entrez:
25
4
2023
Statut:
epublish
Résumé
We examined the longitudinal association between (change in) physical activity (PA) with new onset of five risk factors of metabolic syndrome among 657 middle-aged adults (mean age 44.1 (standard deviation (SD) 8.6) years) who were free of the respective outcome at baseline, in a longitudinal cohort study spanning over 29 years. Levels of habitual PA and sports-related PA were assessed by a self-reported questionnaire. Incident elevated waist circumference (WC), elevated triglycerides (TG), reduced high-density lipoprotein cholesterols (HDL), elevated blood pressure (BP), and elevated blood-glucose (BG) were assessed by physicians and by self-reported questionnaires. We calculated Cox proportional hazard ratio regressions and 95% confidence intervals. Over time, participants developed (cases of incident risk factor; mean (SD) follow-up time) elevated WC (234 cases; 12.3 (8.2) years), elevated TG (292 cases; 11.1 (7.8) years), reduced HDL (139 cases; 12.4 (8.1) years), elevated BP (185 cases; 11.4 (7.5) years), or elevated BG (47 cases; 14.2 (8.5) years). For PA variables at baseline, risk reductions ranging between 37 and 42% for reduced HDL levels were detected. Furthermore, higher levels of PA (≥ 16.6 METh per week) were associated with a 49% elevated risk for incident elevated BP. Participants who increased PA levels over time, had risk reductions ranging between 38 and 57% for elevated WC, elevated TG and reduced HDL. Participants with stable high amounts of PA from baseline to follow-up had risk reductions ranging between 45 and 87% for incident reduced HDL and elevated BG. PA at baseline, starting PA engagement, maintaining and increasing PA level over time are associated with favorable metabolic health outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
We examined the longitudinal association between (change in) physical activity (PA) with new onset of five risk factors of metabolic syndrome among 657 middle-aged adults (mean age 44.1 (standard deviation (SD) 8.6) years) who were free of the respective outcome at baseline, in a longitudinal cohort study spanning over 29 years.
METHODS
METHODS
Levels of habitual PA and sports-related PA were assessed by a self-reported questionnaire. Incident elevated waist circumference (WC), elevated triglycerides (TG), reduced high-density lipoprotein cholesterols (HDL), elevated blood pressure (BP), and elevated blood-glucose (BG) were assessed by physicians and by self-reported questionnaires. We calculated Cox proportional hazard ratio regressions and 95% confidence intervals.
RESULTS
RESULTS
Over time, participants developed (cases of incident risk factor; mean (SD) follow-up time) elevated WC (234 cases; 12.3 (8.2) years), elevated TG (292 cases; 11.1 (7.8) years), reduced HDL (139 cases; 12.4 (8.1) years), elevated BP (185 cases; 11.4 (7.5) years), or elevated BG (47 cases; 14.2 (8.5) years). For PA variables at baseline, risk reductions ranging between 37 and 42% for reduced HDL levels were detected. Furthermore, higher levels of PA (≥ 16.6 METh per week) were associated with a 49% elevated risk for incident elevated BP. Participants who increased PA levels over time, had risk reductions ranging between 38 and 57% for elevated WC, elevated TG and reduced HDL. Participants with stable high amounts of PA from baseline to follow-up had risk reductions ranging between 45 and 87% for incident reduced HDL and elevated BG.
CONCLUSIONS
CONCLUSIONS
PA at baseline, starting PA engagement, maintaining and increasing PA level over time are associated with favorable metabolic health outcomes.
Identifiants
pubmed: 37098550
doi: 10.1186/s13098-023-01062-5
pii: 10.1186/s13098-023-01062-5
pmc: PMC10131386
doi:
Types de publication
Journal Article
Langues
eng
Pagination
82Informations de copyright
© 2023. The Author(s).
Références
J Geriatr Cardiol. 2021 Mar 28;18(3):175-184
pubmed: 33907547
J Health Psychol. 2008 Nov;13(8):1092-104
pubmed: 18987082
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Diabetes Care. 2010 Nov;33(11):2477-83
pubmed: 20693348
Eur J Prev Cardiol. 2021 Oct 13;28(12):1392-1401
pubmed: 34647580
Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S37-40
pubmed: 27052219
Am J Prev Med. 2005 Apr;28(3):267-73
pubmed: 15766614
BMC Public Health. 2020 May 19;20(1):726
pubmed: 32429951
Sci Rep. 2018 Mar 29;8(1):5399
pubmed: 29599426
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Eur J Clin Nutr. 2010 Oct;64(10):1207-14
pubmed: 20588290
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
BMC Med. 2011 May 05;9:48
pubmed: 21542944
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
Obes Rev. 2011 May;12(5):e119-29
pubmed: 20604868
J Am Coll Cardiol. 2011 Mar 15;57(11):1299-313
pubmed: 21392646
Metabolism. 2017 Oct;75:36-44
pubmed: 28927737
Prev Med. 2009 Apr;48(4):326-31
pubmed: 19463487
Nature. 2012 Jan 11;481(7382):463-8
pubmed: 22237023
Curr Sports Med Rep. 2008 May-Jun;7(3):122-5
pubmed: 18477867
Am J Clin Nutr. 2003 Jun;77(6):1417-25
pubmed: 12791618
Obesity (Silver Spring). 2020 Mar;28(3):660-668
pubmed: 32012483
Curr Opin Cardiol. 2018 Jul;33(4):394-401
pubmed: 29762150
Diabetol Metab Syndr. 2021 Mar 2;13(1):25
pubmed: 33653388
Diabetes Res Clin Pract. 2007 Nov;78(2):217-24
pubmed: 17448561
Metabolism. 2014 Apr;63(4):554-61
pubmed: 24559843
Am J Nurs. 1978 Jun;78(6):1039-40
pubmed: 248266
Am J Prev Med. 2004 Nov;27(4):277-83
pubmed: 15488356
Diabetologia. 2007 Mar;50(3):538-44
pubmed: 17221212
Endocrine. 2014 Jun;46(2):231-40
pubmed: 24287790
Int J Med Sci. 2015 Jul 16;12(7):605-12
pubmed: 26283878
PLoS One. 2013 Nov 04;8(11):e77919
pubmed: 24223743
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1417-1426
pubmed: 30315696
BMC Public Health. 2010 Sep 02;10:529
pubmed: 20813031
Arterioscler Thromb Vasc Biol. 2013 May;33(5):1085-91
pubmed: 23559628
Diabetologia. 2020 Jan;63(1):21-33
pubmed: 31482198
Diabetes Care. 2012 Sep;35(9):1876-83
pubmed: 22751959
Eur J Public Health. 2018 Oct 1;28(5):944-950
pubmed: 29554269
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
Eur J Clin Nutr. 2017 Apr;71(4):519-524
pubmed: 27623984
Mayo Clin Proc. 2014 Jun;89(6):722-6
pubmed: 24809757
Prev Med. 2018 Jul;112:31-37
pubmed: 29605421
Eur J Sport Sci. 2017 Sep;17(8):1090-1099
pubmed: 28747143
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1217-1224
pubmed: 32682310
Pharmacol Res. 2017 Jun;120:34-42
pubmed: 28300617
Am J Public Health Nations Health. 1951 Mar;41(3):279-81
pubmed: 14819398
ISRN Cardiol. 2012;2012:718789
pubmed: 23198160
Obes Res. 1998 Sep;6 Suppl 2:51S-209S
pubmed: 9813653
Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):309-13
pubmed: 20300002
Diabetologia. 2013 May;56(5):1031-5
pubmed: 23404445
Am J Epidemiol. 1978 Sep;108(3):161-75
pubmed: 707484
Curr Sports Med Rep. 2016 May-Jun;15(3):207-14
pubmed: 27172086
Soc Work Health Care. 2008;46(4):57-79
pubmed: 18589564
J Lipid Res. 2009 Aug;50(8):1685-91
pubmed: 19346332
Sports (Basel). 2019 May 23;7(5):
pubmed: 31126126
Nutrients. 2019 Jul 19;11(7):
pubmed: 31331009